Journal of Gastroenterology

Papers
(The TQCC of Journal of Gastroenterology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Evidence-based clinical practice guidelines for inflammatory bowel disease 2020249
Evidence-based clinical practice guidelines for Liver Cirrhosis 2020203
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020144
Evidence-based clinical practice guidelines for peptic ulcer disease 2020114
Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2021109
Evidence-based clinical practice guidelines for irritable bowel syndrome 202088
JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis75
Reducing adenoma miss rate of colonoscopy assisted by artificial intelligence: a multicenter randomized controlled trial65
Risk of cardiovascular disease in patients with fatty liver disease as defined from the metabolic dysfunction associated fatty liver disease or nonalcoholic fatty liver disease point of view: a retros58
Evidence-based clinical practice guidelines for functional dyspepsia 202156
Evidence-based clinical practice guidelines for management of colorectal polyps55
The transition in the etiologies of hepatocellular carcinoma-complicated liver cirrhosis in a nationwide survey of Japan43
Amendment of the Japanese consensus guidelines for autoimmune pancreatitis, 202041
Leucine-rich alpha-2 glycoprotein is a potential biomarker to monitor disease activity in inflammatory bowel disease receiving adalimumab: PLANET study39
COVID-19-associated liver injury: from bedside to bench39
Tenofovir–disoproxil–fumarate modulates lipid metabolism via hepatic CD36/PPAR-alpha activation in hepatitis B virus infection35
Gastric epithelial neoplasm of fundic-gland mucosa lineage: proposal for a new classification in association with gastric adenocarcinoma of fundic-gland type35
Emerging role and therapeutic application of exosome in hepatitis virus infection and associated diseases34
Lactobacillus stress protein GroEL prevents colonic inflammation34
Residual HBV DNA and pgRNA viraemia is associated with hepatocellular carcinoma in chronic hepatitis B patients on antiviral therapy33
Gastric cancer and genomics: review of literature33
A review on the current status and definitions of activity indices in inflammatory bowel disease: how to use indices for precise evaluation32
Pathogenic effects of Desulfovibrio in the gut on fatty liver in diet-induced obese mice and children with obesity31
Applicability of APRI and FIB-4 as a transition indicator of liver fibrosis in patients with chronic viral hepatitis31
The characteristics of gastrointestinal symptoms in patients with severe COVID-19: a systematic review and meta-analysis31
Artificial intelligence (AI) models for the ultrasonographic diagnosis of liver tumors and comparison of diagnostic accuracies between AI and human experts30
Circular RNA TMEM87A promotes cell proliferation and metastasis of gastric cancer by elevating ULK1 via sponging miR-142-5p30
Artificial intelligence automates and augments baseline impedance measurements from pH-impedance studies in gastroesophageal reflux disease29
Utility of artificial intelligence with deep learning of hematoxylin and eosin-stained whole slide images to predict lymph node metastasis in T1 colorectal cancer using endoscopically resected specime29
Direct-acting antivirals improve survival and recurrence rates after treatment of hepatocellular carcinoma within the Milan criteria28
Hepatocellular carcinoma development in diabetic patients: a nationwide survey in Japan28
Histopathological characteristics and artificial intelligence for predicting tumor mutational burden-high colorectal cancer26
Risk of metastatic recurrence after endoscopic resection for esophageal squamous cell carcinoma invading into the muscularis mucosa or submucosa: a multicenter retrospective study26
The gut mycobiome: a novel player in chronic liver diseases26
Evidence-based clinical practice guidelines for chronic pancreatitis 202126
STING and liver disease24
Induction therapy with hepatic arterial infusion chemotherapy enhances the efficacy of lenvatinib and pd1 inhibitors in treating hepatocellular carcinoma patients with portal vein tumor thrombosis24
Clinical practice advice on lifestyle modification in the management of nonalcoholic fatty liver disease in Japan: an expert review23
Renal manifestations in inflammatory bowel disease: a systematic review23
HBeAg-positive patients with HBsAg  < 100 IU/mL and negative HBV RNA have lower risk of virological relapse after nucleos(t)ide analogues cessation23
Liver-related events after direct-acting antiviral therapy in patients with hepatitis C virus-associated cirrhosis22
Clinical practice guidelines for duodenal cancer 202122
Enhanced endoscopic detection of occult gastric cancer in carriers of pathogenic CDH1 variants21
Tenofovir vs. entecavir on prognosis of hepatitis B virus-related hepatocellular carcinoma after curative resection21
Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: a phase 2 multicenter study20
Omics profiles of fecal and oral microbiota change in irritable bowel syndrome patients with diarrhea and symptom exacerbation20
CCL19 enhances CD8+ T-cell responses and accelerates HBV clearance20
A simple prediction score for in-hospital mortality in patients with nonvariceal upper gastrointestinal bleeding19
Evidence-based clinical practice guidelines for cholelithiasis 202119
Comorbidities and healthcare costs and resource use of patients with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) in the Japan medical data vision database19
A systematic review of the prevalence of germline pathogenic variants in patients with pancreatic cancer19
Proportion of unresectable pancreatic cancer specimens obtained by endoscopic ultrasound-guided tissue acquisition meeting the OncoGuide™ NCC Oncopanel System analysis suitability criteria: a single-a18
Wilson disease: revision of diagnostic criteria in a clinical series with great genetic homogeneity18
Ursodeoxycholic acid for the prevention of gallstones and subsequent cholecystectomy after bariatric surgery: a meta-analysis of randomized controlled trials17
Genomic landscape and clinical features of rare subtypes of pancreatic cancer: analysis with the national database of Japan17
Distinct prognostic value of different portal hypertension-associated features in patients with primary biliary cholangitis16
Targeting autophagy as a therapeutic strategy against pancreatic cancer16
Mucosal IL23A expression predicts the response to Ustekinumab in inflammatory bowel disease15
Deep learning-based automated quantification of goblet cell mucus using histological images as a predictor of clinical relapse of ulcerative colitis with endoscopic remission15
Achalasia and esophageal cancer: a large database analysis in Japan15
Prevention of delayed bleeding with vonoprazan in upper gastrointestinal endoscopic treatment15
MAFLD: an optimal framework for understanding liver cancer phenotypes15
A novel risk factor panel predicts early recurrence in resected pancreatic neuroendocrine tumors14
Pathways for the development of multiple epithelial types of intraductal papillary mucinous neoplasm of the pancreas14
The clinical efficacy of azathioprine as maintenance treatment for autoimmune pancreatitis: a systematic review and meta-analysis14
Supportive treatment during the periprocedural period of endoscopic treatment for pancreatic fluid collections: a critical review of current knowledge and future perspectives14
Integrated analysis of tertiary lymphoid structures in relation to tumor-infiltrating lymphocytes and patient survival in pancreatic ductal adenocarcinoma13
Post-treatment cell-free DNA as a predictive biomarker in molecular-targeted therapy of hepatocellular carcinoma13
Effect of gastric cancer screening on long-term survival of gastric cancer patients: results of Korean national cancer screening program13
Diagnostic criteria and endoscopic and histological findings of autoimmune gastritis in Japan13
The clinical outcome from early versus delayed minimally invasive intervention for infected pancreatic necrosis: a systematic review and meta-analysis13
Oral administration of d-serine prevents the onset and progression of colitis in mice13
Treatment escalation and de-escalation decisions in Crohn’s disease: Delphi consensus recommendations from Japan, 202113
Adrenomedullin for steroid-resistant ulcerative colitis: a randomized, double-blind, placebo-controlled phase-2a clinical trial13
Surgical results of non-ampullary duodenal cancer: a nationwide survey in Japan13
New insights into irritable bowel syndrome pathophysiological mechanisms: contribution of epigenetics13
Novel probiotic yeast from Miso promotes regulatory dendritic cell IL-10 production and attenuates DSS-induced colitis in mice13
Autoimmune gastritis induces aberrant DNA methylation reflecting its carcinogenic potential12
Mucosal and faecal neutrophil gelatinase-associated lipocalin as potential biomarkers for collagenous colitis12
Ferroptosis in the colon epithelial cells as a therapeutic target for ulcerative colitis12
Effect of blood product transfusion on the prognosis of patients undergoing hepatectomy for hepatocellular carcinoma: a propensity score matching analysis12
Nationwide survey for patients with acute-on-chronic liver failure occurring between 2017 and 2019 and diagnosed according to proposed Japanese criteria12
Ulcerative colitis-related severe enteritis: an infrequent but serious complication after colectomy11
Characteristics of colorectal neuroendocrine tumors in patients prospectively enrolled in a Japanese multicenter study: a first report from the C-NET STUDY11
Features of the gut prokaryotic virome of Japanese patients with Crohn’s disease11
Pro- and anti-inflammatory roles of interleukin (IL)-33, IL-36, and IL-38 in inflammatory bowel disease11
Excessive risk of second-cancer incidence and cancer mortality in patients with esophageal cancer11
Characteristics of adult patients newly diagnosed with Crohn’s disease: interim analysis of the nation-wide inception cohort registry study of patients with Crohn’s disease in Japan (iCREST-CD)11
The impact of sarcopenia on short- and long-term outcomes of endoscopic submucosal dissection for early gastric cancer11
T follicular helper cells improve the response of patients with chronic hepatitis B to interferon by promoting HBsAb production11
Clinical features and oncological outcomes of intestinal cancers associated with ulcerative colitis and Crohn’s disease11
Environmental factors, medical and family history, and comorbidities associated with primary biliary cholangitis in Japan: a multicenter case–control study11
Gender difference in the overlap of irritable bowel syndrome and functional dyspepsia: a prospective nationwide multicenter study in Korea10
Molecular mechanisms of pancreatic myofibroblast activation in chronic pancreatitis and pancreatic ductal adenocarcinoma10
Adjuvant immune checkpoint inhibitors associated with higher recurrence-free survival in postoperative hepatocellular carcinoma (PREVENT): a prospective, multicentric cohort study10
Efficacy and safety of vonoprazan-based regimen for Helicobacter pylori eradication therapy in Japanese adolescents: a prospective multicenter study10
Systematic review and meta-analysis: analysis of variables influencing the interpretation of clinical trial results in NAFLD10
Sessile serrated lesions with dysplasia: is it possible to nip them in the bud?10
Prognostic role of detailed colorectal location and tumor molecular features: analyses of 13,101 colorectal cancer patients including 2994 early-onset cases10
Both fecal calprotectin and fecal immunochemical tests are useful in children with inflammatory bowel disease10
The impact of the age-adjusted Charlson comorbidity index as a prognostic factor for endoscopic papillectomy in ampullary tumors10
Splenic non-infarction volume determines a clinically significant hepatic venous pressure gradient response to partial splenic embolization in patients with cirrhosis and hypersplenism9
Current status of type 1 (IgG4-related) autoimmune pancreatitis9
Hepatitis C virus eradication prolongs overall survival in hepatocellular carcinoma patients receiving molecular-targeted agents9
Ratio of submucosal thickness to total bowel wall thickness as a new sonographic parameter to estimate endoscopic remission of ulcerative colitis9
Differential diagnosis of superficial duodenal epithelial tumor and non-neoplastic lesion in duodenum by magnified endoscopic examination with image-enhanced endoscopy9
Proton-pump inhibitors are associated with a high false-positivity rate in faecal immunochemical testing9
Successful induction of human chemically induced liver progenitors with small molecules from damaged liver9
Predictive factors for subsequent intrahepatic cholangiocarcinoma associated with hepatolithiasis: Japanese National Cohort Study for 18 years9
Mutant GNAS limits tumor aggressiveness in established pancreatic cancer via antagonizing the KRAS-pathway9
Comprehensive aptamer-based screen of 1317 proteins uncovers improved stool protein markers of colorectal cancer9
Safety and efficacy of lenvatinib by starting dose based on body weight in patients with unresectable hepatocellular carcinoma in REFLECT9
0.044394016265869